Related Experiment Video
Updated: Jul 15, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients
Gilli Galore1, Esther Azizi, Alon Scope
1Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel.
Abstract:
MC1R sequence variants are associated with malignant melanoma risk, and most commonly are missense mutations. Few (n=9) truncating mutations have been described in this gene as predisposing to malignant melanoma. In this study, three Jewish individuals were found to harbor an identical truncating MC1R mutation--Y152X: an Ashkenazi patient with two malignant melanomas, a non-Ashkenazi malignant melanoma patient with familial malignant melanoma and her asymptomatic mother. Both malignant melanoma patients carried additional, seemingly pathogenic MC1R variants. Haplotype analysis revealed that all three mutation carriers shared the same haplotype. This sequence variant was previously described in ethnically diverse, non-Jewish individuals and in all likelihood represents an error-prone domain that, in conjunction with other genetic and environmental factors, increases malignant melanoma risk.
Insights
A rare truncating mutation in the Melanocortin 1 Receptor (MC1R) gene, Y152X, was identified in Jewish individuals with malignant melanoma. This MC1R variant likely increases cancer risk alongside other genetic and environmental factors.
Area of Science:
- Genetics
- Dermatology
- Oncology
Background:
- Melanocortin 1 Receptor (MC1R) sequence variants are linked to malignant melanoma risk, predominantly as missense mutations.
- Only a small number (n=9) of truncating MC1R mutations predisposing to malignant melanoma have been documented.
- MC1R plays a crucial role in skin pigmentation and DNA repair, influencing susceptibility to UV-induced damage.
Purpose of the Study:
- To investigate the role of a specific truncating MC1R mutation (Y152X) in Jewish individuals with malignant melanoma.
- To determine if this mutation is a shared founder mutation within the studied population.
- To explore the combined effect of MC1R variants and other factors in melanoma development.
Main Methods:
- Genetic sequencing to identify MC1R mutations.
- Haplotype analysis to assess shared ancestry among mutation carriers.
- Clinical data review of patients with malignant melanoma and their families.
Main Results:
- Three Jewish individuals, including an Ashkenazi patient with multiple melanomas and a non-Ashkenazi patient with familial melanoma, shared an identical truncating MC1R mutation (Y152X).
- Both affected patients carried additional potentially pathogenic MC1R variants.
- Haplotype analysis confirmed a shared haplotype among the three Y152X mutation carriers.
Conclusions:
- The Y152X MC1R mutation is present in Jewish individuals and may represent a founder mutation.
- This truncating MC1R variant, particularly in conjunction with other genetic and environmental factors, likely contributes to malignant melanoma risk.
- Further research into MC1R's error-prone domains is warranted to understand melanoma predisposition.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-LTR Retrotransposons
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
